Evidence map›Paper›PMID 25213154›Full record

ArticleBulletin of mathematical biology2015

Understanding, treating and avoiding hematological disease: better medicine through mathematics?

David C Dale, Michael C Mackey

Abstract read
In one paragraph

Article in Bulletin of mathematical biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Transit and lifespan in neutrophil production: implications for drug intervention.Journal of pharmacokinetics and pharmacodynamics · 2018
    Article
  4. Severe congenital neutropenias.Nature reviews. Disease primers · 2017
    Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

David C DaleDepartment of Medicine, University of Washington, Seattle, WA, 98195, USA, dcdale@u.washington.edu.
Michael C Mackey
McGill University · CAUniversity of Washington · US

Funding

Severe Chronic Neutropenia International RegistryR24AI049393 · NIAID · UNIVERSITY OF WASHINGTON · PI DALE, DAVID CHANDLER · 2004 to 2019
$10.6M
NIAID NIH HHS R24 AI049393
6 · The paper itself

Abstract

This paper traces the experimental, clinical and mathematical modeling efforts to understand a periodic hematological disease-cyclical neutropenia. It is primarily a highly personal account by two scientists from quite different backgrounds of their interactions over almost 40 years and their attempts to understand this intriguing disease. It's also a story of their efforts to offer effective treatments for the patients who suffer from cyclic neutropenia and other conditions causing neutropenia and infections.

Indexed as

Models, BiologicalAnimalsAntineoplastic AgentsGranulocyte Colony-Stimulating FactorHematologic DiseasesHumansMathematical ConceptsNeutropeniaAntineoplastic AgentsGranulocyte Colony-Stimulating Factor

Identifiers

PMID25213154
PMCPMC4362913
OpenAlexW2075298888

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.